Intravitreal bevacizumab (Avastin®) for radiation retinopathy neovascularization

被引：14

作者：

Arriola-Vilialobos, Pedro ^{[1
]}

Donate-Lopez, Juan ^{[2
]}

Calvo-Gonzalez, Cristina ^{[1
]}

Reche-Frutos, Juan ^{[1
]}

Alejandre-Alba, Nicolas ^{[1
]}

Diaz-Valle, David ^{[1
]}

机构：

[1] Univ Complutense Madrid, Ophthalmol Unit, Hosp Clin San Carlos, Madrid, Spain

[2] Donate Ophthalmol Ctr, Cuenca, Spain

来源：

ACTA OPHTHALMOLOGICA | 2008年 / 86卷 / 01期

关键词：

D O I：

10.1111/j.1600-0420.2007.00977.x

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：115 / 116

页数：2

共 5 条

[1] Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy [J].

Avery, Robert L. ;

Pearlman, Joel ;

Pieramici, Dante J. ;

Rabena, Melvin D. ;

Castellarin, Alessandro A. ;

Nasir, Ma'an A. ;

Giust, Matthew J. ;

Wendel, Robert ;

Patel, Arun .

OPHTHALMOLOGY, 2006, 113 (10) :1695-1705

[2] Proliferative radiation retinopathy [J].

Kinyoun, JL ;

Lawrence, BS ;

Barlow, WE .

ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (09) :1097-1100

[3]

MAGUIRE AM, 2001, RETINA, P1509

[4] Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy [J].

Siqueira, Rubens C. ;

Costa, Rogerio A. ;

Scott, Ingrid U. ;

Cintra, Lessia P. ;

Jorge, Rodrigo .

ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (06) :834-835

[5] Late retinal complications of radiation therapy for nasal and paranasal malignancies: Relationship between irradiated-dose area and severity [J].

Takeda, A ;

Shigematsu, N ;

Suzuki, S ;

Fujii, M ;

Kawata, T ;

Kawaguchi, O ;

Uno, T ;

Takano, H ;

Kubo, A ;

Ito, H .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03) :599-605

← 1 →